FINNENCE ▪ THE WIRE FILE
THE WIRE · № 75657
News■ Unclear/unknown
Keenova Presents a New TERLIVAZ® (terlipressin) Exploratory Analysis at American College of Gastroenterology Annual Meeting
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A conference presentation on an existing drug offers no new efficacy or revenue data, so it is unlikely to shift estimates.
Routine scientific presentation, not a commercial catalyst
CATALYST TO WATCH
Peer commentary or new trial data
MAIN RISK
No material financial disclosure in release
FULL DISPATCH
DUBLIN, Oct. 12, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS‑AKI) and TERLIVAZ® (terlipressin) will be shared at the American College of Gastroenterology Annual Meeting, taking place October 9-14,...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Retension Pharmaceuticals exceeds target with $45M IPO2026-10-12 11:53 UTC
Retension Pharmaceuticals exceeds target with $45M IPO2026-10-12 11:53 UTC
→CORRELATIONshares Healthcare
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway2026-10-12 12:00 UTC
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway2026-10-12 12:00 UTC
→CORRELATIONshares Healthcare
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare2026-10-12 12:00 UTC
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare2026-10-12 12:00 UTC
→CORRELATIONshares Healthcare
Accord BioPharma Launches FILKRI™ (filgrastim-laha); Now Offers Both Long- and Short-Acting G-CSF Options2026-10-12 12:05 UTC
Accord BioPharma Launches FILKRI™ (filgrastim-laha); Now Offers Both Long- and Short-Acting G-CSF Options2026-10-12 12:05 UTC
→CORRELATIONshares Healthcare
Wisner Baum Lawsuit Alleges Syngenta Failed to Warn of Atrazine's Cancer Risks2026-10-12 12:09 UTC
Wisner Baum Lawsuit Alleges Syngenta Failed to Warn of Atrazine's Cancer Risks2026-10-12 12:09 UTC
→CORRELATIONshares Healthcare
Another Healthcare Increase Is Coming. Are Employers Watching the Spending Closely Enough?2026-10-12 12:09 UTC
Another Healthcare Increase Is Coming. Are Employers Watching the Spending Closely Enough?2026-10-12 12:09 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.